Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > BNN

<< Previous

Bullboard Posts

Next >>

Comment by canadafanon Oct 08, 2024 12:21pm

256 Views

Post# 36257991

RE:RE:RE:RE:RE:RE:RE:BNN

The Sp increases 50% in a few days.almost doubled in a fe2 weeks.
Then , Healthy profit taking.expected.
None of the fundamentals have changed.
still in line to seek accelerated approval.
still in line to start pancreatic cancer trial, with CGAR .
As I said many times the day- day price only matters if buying or selling.
The day traders are day trading. Again, read the company investor publications.
that BTW did not change even one syllable, as a result of the price run up, or todsys correction.
what matters, long term is getting Pela approved as a cancer drug.
then, the true " value" Will be revealed.

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant